Treatment of high risk myelodysplatic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)

Saved in:
Bibliographic Details
Published in:Leukemia research 1996, Vol.20 (5), p.385-390
Main Authors: ECONOMOPOULOS, T, PAPAGEORGIOU, E, STATHAKIS, N, CONSTANTINIDOU, M, PARHARIDOU, A, KOSTOUROU, A, DERVENOULAS, J, RAPTIS, S
Format: Article
Language:English
Subjects:
Antineoplastic agents
Biological and medical sciences
Chemotherapy
Medical sciences
Pharmacology. Drug treatments
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 390
container_issue 5
container_start_page 385
container_title Leukemia research
container_volume 20
creator ECONOMOPOULOS, T
PAPAGEORGIOU, E
STATHAKIS, N
CONSTANTINIDOU, M
PARHARIDOU, A
KOSTOUROU, A
DERVENOULAS, J
RAPTIS, S
description
format article
fullrecord <record><control><sourceid>pascalfrancis</sourceid><recordid>TN_cdi_pascalfrancis_primary_3106670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3106670</sourcerecordid><originalsourceid>FETCH-pascalfrancis_primary_31066703</originalsourceid><addsrcrecordid>eNqNjb1OwzAURiMEEuXnHe7AAIMlpyFpO1cUFqZ2r25sJ7ngP_k6Qn4aXpUg8QBM5xuOvnNRrertphHttmkvq5Wsn1uxrtfddXXD_CGlbHf1blV9n5LB7IzPEAaYaJwgEX-CK8YGXThazKSAi9cpOMPwRXkC0pjmnhR5QK9BlRyYvAFM2JNftjbAc4whZaOhLzAm9LMNi2iEQ5VCnHA0oIINvgjO5ObfkB9hQJVDgsfXd7E_Hp7uqqsBLZv7P95WD4eX0_5NRGSFdlh-FfE5JnKYyrmpZddtZPNP7QcJzGCV</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Treatment of high risk myelodysplatic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)</title><source>ScienceDirect Freedom Collection</source><creator>ECONOMOPOULOS, T ; PAPAGEORGIOU, E ; STATHAKIS, N ; CONSTANTINIDOU, M ; PARHARIDOU, A ; KOSTOUROU, A ; DERVENOULAS, J ; RAPTIS, S</creator><creatorcontrib>ECONOMOPOULOS, T ; PAPAGEORGIOU, E ; STATHAKIS, N ; CONSTANTINIDOU, M ; PARHARIDOU, A ; KOSTOUROU, A ; DERVENOULAS, J ; RAPTIS, S</creatorcontrib><identifier>ISSN: 0145-2126</identifier><identifier>EISSN: 1873-5835</identifier><identifier>CODEN: LEREDD</identifier><language>eng</language><publisher>Oxford: Elsevier Science</publisher><subject>Antineoplastic agents ; Biological and medical sciences ; Chemotherapy ; Medical sciences ; Pharmacology. Drug treatments</subject><ispartof>Leukemia research, 1996, Vol.20 (5), p.385-390</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4021</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=3106670$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>ECONOMOPOULOS, T</creatorcontrib><creatorcontrib>PAPAGEORGIOU, E</creatorcontrib><creatorcontrib>STATHAKIS, N</creatorcontrib><creatorcontrib>CONSTANTINIDOU, M</creatorcontrib><creatorcontrib>PARHARIDOU, A</creatorcontrib><creatorcontrib>KOSTOUROU, A</creatorcontrib><creatorcontrib>DERVENOULAS, J</creatorcontrib><creatorcontrib>RAPTIS, S</creatorcontrib><title>Treatment of high risk myelodysplatic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)</title><title>Leukemia research</title><subject>Antineoplastic agents</subject><subject>Biological and medical sciences</subject><subject>Chemotherapy</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><issn>0145-2126</issn><issn>1873-5835</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNqNjb1OwzAURiMEEuXnHe7AAIMlpyFpO1cUFqZ2r25sJ7ngP_k6Qn4aXpUg8QBM5xuOvnNRrertphHttmkvq5Wsn1uxrtfddXXD_CGlbHf1blV9n5LB7IzPEAaYaJwgEX-CK8YGXThazKSAi9cpOMPwRXkC0pjmnhR5QK9BlRyYvAFM2JNftjbAc4whZaOhLzAm9LMNi2iEQ5VCnHA0oIINvgjO5ObfkB9hQJVDgsfXd7E_Hp7uqqsBLZv7P95WD4eX0_5NRGSFdlh-FfE5JnKYyrmpZddtZPNP7QcJzGCV</recordid><startdate>1996</startdate><enddate>1996</enddate><creator>ECONOMOPOULOS, T</creator><creator>PAPAGEORGIOU, E</creator><creator>STATHAKIS, N</creator><creator>CONSTANTINIDOU, M</creator><creator>PARHARIDOU, A</creator><creator>KOSTOUROU, A</creator><creator>DERVENOULAS, J</creator><creator>RAPTIS, S</creator><general>Elsevier Science</general><scope>IQODW</scope></search><sort><creationdate>1996</creationdate><title>Treatment of high risk myelodysplatic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)</title><author>ECONOMOPOULOS, T ; PAPAGEORGIOU, E ; STATHAKIS, N ; CONSTANTINIDOU, M ; PARHARIDOU, A ; KOSTOUROU, A ; DERVENOULAS, J ; RAPTIS, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pascalfrancis_primary_31066703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antineoplastic agents</topic><topic>Biological and medical sciences</topic><topic>Chemotherapy</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ECONOMOPOULOS, T</creatorcontrib><creatorcontrib>PAPAGEORGIOU, E</creatorcontrib><creatorcontrib>STATHAKIS, N</creatorcontrib><creatorcontrib>CONSTANTINIDOU, M</creatorcontrib><creatorcontrib>PARHARIDOU, A</creatorcontrib><creatorcontrib>KOSTOUROU, A</creatorcontrib><creatorcontrib>DERVENOULAS, J</creatorcontrib><creatorcontrib>RAPTIS, S</creatorcontrib><collection>Pascal-Francis</collection><jtitle>Leukemia research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ECONOMOPOULOS, T</au><au>PAPAGEORGIOU, E</au><au>STATHAKIS, N</au><au>CONSTANTINIDOU, M</au><au>PARHARIDOU, A</au><au>KOSTOUROU, A</au><au>DERVENOULAS, J</au><au>RAPTIS, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Treatment of high risk myelodysplatic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)</atitle><jtitle>Leukemia research</jtitle><date>1996</date><risdate>1996</risdate><volume>20</volume><issue>5</issue><spage>385</spage><epage>390</epage><pages>385-390</pages><issn>0145-2126</issn><eissn>1873-5835</eissn><coden>LEREDD</coden><cop>Oxford</cop><pub>Elsevier Science</pub></addata></record>
fulltext fulltext
identifier ISSN: 0145-2126
ispartof Leukemia research, 1996, Vol.20 (5), p.385-390
issn 0145-2126
1873-5835
language eng
recordid cdi_pascalfrancis_primary_3106670
source ScienceDirect Freedom Collection
subjects Antineoplastic agents
Biological and medical sciences
Chemotherapy
Medical sciences
Pharmacology. Drug treatments
title Treatment of high risk myelodysplatic syndromes with idarubicin and cytosine arabinoside supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T20%3A33%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pascalfrancis&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Treatment%20of%20high%20risk%20myelodysplatic%20syndromes%20with%20idarubicin%20and%20cytosine%20arabinoside%20supported%20by%20granulocyte-macrophage%20colony-stimulating%20factor%20(GM-CSF)&rft.jtitle=Leukemia%20research&rft.au=ECONOMOPOULOS,%20T&rft.date=1996&rft.volume=20&rft.issue=5&rft.spage=385&rft.epage=390&rft.pages=385-390&rft.issn=0145-2126&rft.eissn=1873-5835&rft.coden=LEREDD&rft_id=info:doi/&rft_dat=%3Cpascalfrancis%3E3106670%3C/pascalfrancis%3E%3Cgrp_id%3Ecdi_FETCH-pascalfrancis_primary_31066703%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true